Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Me... I prefer chicken! LOL
Not now!
Is anyone in a position to post L2?
How many shares will it take to get rid of the .005 seller?
Nice open.... so far
Nutrition 21 Launches Breakthrough Weight Management Product: Iceland Health(R) 'Appetite Control Formula'
Last update: 2/3/2009 7:30:00 AMPURCHASE, N.Y., Feb 03, 2009 /PRNewswire via COMTEX/ -- Clinical evidence supports potential to reduce cravings, hunger levels, appetite, and food intake by as much as 25% Nutrition 21, Inc. (NXXI), the developer and marketer of nutritional supplements under the Iceland Health(R) brand launched a potential breakthrough weight management product this week: "Iceland Health Appetite Control Formula(TM)." This safe, all natural high-quality product is expected to reduce cravings, hunger levels, appetite, and food intake by as much as 25%. In select markets, 30-minute TV infomercials began running on January 22, 2009. In early February, a national direct response advertising campaign is planned to introduce this new product to consumers. Additional information on Iceland Health Appetite Control Formula(TM) can be accessed at the product website: . This innovative weight management product is based on the powerful results of a randomized, double-blind, placebo-controlled study of Nutrition 21's Chromax(R) Chromium Picolinate (patented for reduction of food cravings), conducted by key researchers at the Pennington Biomedical Research Center, the largest academically-based nutrition research center in the world. Those tests demonstrated that Chromax, the key ingredient in Iceland Health Appetite Control Formula(TM), can suppress appetite by as much as 25% without the typical side effects commonly associated with other diet products on the market today. Results of the study can be reviewed on the Nutrition 21 website: . Pam McWilliams, vice president and general manager of Nutrition 21's Direct Response division, commented, "We are excited with the possibilities that this product offers to people struggling to manage their weight and their overall health profile. We believe that consumers will value the ability to curb appetite without the usual side effects - jitteriness, unpleasant digestive issues, sleep loss, etc. - that are part and parcel of many weight loss products." "Consumers can be assured of the safety profile of this product as our chromium picolinate was deemed safe by a National Toxicology Program study reported in 2008," continued Ms. McWilliams. "In addition to the efficacy of our chromium picolinate to reduce cravings, hunger levels and appetite, as demonstrated by the Pennington Biomedical Research Center clinical study, Iceland Health Appetite Control Formula(TM) can be an effective and cost-efficient tool within the framework of a sensible weight loss program to help people achieve a sustainable quality of life improvement." Michael A. Zeher, president and chief executive officer of Nutrition 21, Inc. concluded, "Iceland Health Appetite Control Formula(TM) is another example of the ability of Nutrition 21 to translate important scientific findings into commercial value for shareholders. With a patent covering the use of the key ingredient for reducing food cravings and appetite, Nutrition 21 is, again, taking the lead with safe and effective science-based products for our customers and consumers seeking solutions to their healthcare needs." About Pennington Biomedical Research Center The Pennington Biomedical Research Center mission is to promote healthier lives through research and education in nutrition and preventive medicine. The Center is a campus of the Louisiana State University System and conducts basic, clinical and population research. The research enterprise at the Center includes 80 faculty and more than 40 post-doctoral fellows who comprise a network of 50 laboratories supported by lab technicians, nurses, dietitians, and support personnel, and 19 highly specialized core service facilities. The Center's nearly 600 employees occupy several buildings on the 234-acre campus. About Nutrition 21 Nutrition 21, Inc. (NXXI), headquartered in Purchase, NY, is a nutritional bioscience company and the maker of chromium picolinate-based and omega-3 fish oil-based supplements with health benefits substantiated by clinical research. Nutrition 21 holds more than 30 patents for nutrition products and uses. Nutrition 21's portfolio of health and wellness products include: Iceland Health Chromax, Iceland Health Advanced Memory Formula(TM), Iceland Health Omega-3 Fish Oil, Iceland Health Joint Relief, and Diabetes Essentials(R) The company also manufactures private label supplements and ingredients for third parties. Nutrition 21 distributes its products nationally through more than 30,000 major food, drug and super center stores throughout the United States and internationally. For more information please visit . Safe Harbor Provision This press release may contain certain forward-looking statements. The words "believe," "expect," "anticipate" and other similar expressions generally identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates. These forward-looking statements are based largely on the Company's current expectations and are subject to a number of risks and uncertainties, including without limitation: the effect of the expiration of patents; regulatory issues; uncertainty in the outcomes of clinical trials; changes in external market factors; changes in the Company's business or growth strategy or an inability to execute its strategy due to changes in its industry or the economy generally; the emergence of new or growing competitors; various other competitive factors; and other risks and uncertainties indicated from time to time in the Company's filings with the Securities and Exchange Commission, including its Form 10-K/A for the year ended June 30, 2008. Actual results could differ materially from the results referred to in the forward-looking statements. In light of these risks and uncertainties, there can be no assurance that the results referred to in the forward-looking statements contained in this press release will in fact occur. Additionally, the Company makes no commitment to disclose any revisions to forward-looking statements, or any facts, events or circumstances after the date hereof that may bear upon forward-looking statements.
Company Contact: Investor Contact: Alan Kirschbaum Joe Diaz, Robert Blum, Joe Dorame Chief Financial Officer Lytham Partners, LLC (914) 701-4500 (602) 889-9700 nxxi@lythampartners.comSOURCE Nutrition 21, Inc.
Copyright (C) 2009 PR Newswire. All rights reserved
HUH???? Zero volume is short covering?
Word is slowly trickling out, and people are starting to become interested in this again.
And that is saying a lot for you! Thanks for the update.
There are plans, how quick they become reality is another question. There are plans to get this completely compliant so it becomes easier to move forward when the time comes.
I'm still in this thing as I have not read anything that would be a negative for it to continue to drop like it has. Anything idea on your part why this has continue to drop?
Only if you make less than $250, otherwise your safe, your buds in Washington will take care of you with another tax cut. LOL
Yup.
Tim,
If you have access to those who state they are trying to pull this together, you might want to stress to them that it's time they S**T or got off of the pot. I have a lot of patience, but even they are starting to unnerve me with their lack of progress or communication.
Let us know.
I believe in JB as well, the problem is, that at this time he is out of the process and out of the loop, as he should. But somehow, someway, somebody needs to light a match under their somea**!
$1.00 printed!
No... Stupid programmer!
Not sure what Rex's point was, but I do find it eerily coincidental that the six month restriction was up on the same date the Cancen deal was cancelled. Odd!
Current management needs to acknowledge that they still exist. That's all anybody wants right now. They don't have to give any info, just let us know that you haven't completely abandoned this shell.
Yup, about 3 weeks ago. Got some company that had no idea what I was talking about. I like to know if anyone else has tried with success.
Here monitoring, just not a whole lot to talk about.
I'm guessing you're not planning on sending them a Christmas card? I'm guessing they were not hired for their communications skills (or lack of)! They need to S**T or get off of the pot and let someone who has the fortitude to move this forward to get behind the wheel!!!
Great reading, thanks for the link.
Dang! Missed by one letter!
CCMJ
Thursday, August 07 2008 9:45 AM, EST CruiseCam International Moves Forward With Patents in Europe Market Wire "US Press Releases "
I hope they don't insult our intelligence by stating "Thanks for your patience"! They need to come out an apologize for being so unresponsive to those whom have suffered over the past years.
Just tried to call IR. It's not CCAJ investor relations!
Rich,
You aren't alone. Been here for sometime as well, with a touch north of 20k invested. It has been frustrating to say the least. I know management is supposedly finishing up on the R/M and need to remain quiet, but keeping us in the dark for so long is ridiculous. They need to begin wrapping this process up and/or at least provide us with some type of update.
Appreciate the info.
Sent an e-mail to Tom H. as well, received a rather quick reply. Stated that there will be a corporate update shortly and that 2nd Q financials are expected out this week. This will be followed by a shareholder update of the previously announced spin-out.
News this AM
CGSE to List on OTC Bulletin BoardLast update: 7/21/2008 9:20:00 AMLAS VEGAS, July 21, 2008 /PRNewswire-FirstCall via COMTEX/ -- Columbus Geographic Systems (GIS) Ltd. ("Columbus") (Pink Sheets: CGSE) announced today that as part of its effort to upgrade its publicly traded status, an authorized NASD member firm has filed a Form 15c-211 with the NASD. This should qualify the company for a listing on the OTC Electronic Bulletin Board. This follows the announcement on December 10, 2007 that the Company filed Form 10-SB12G with the Securities and Exchange Commission (SEC) to become a fully reporting company. (The full Form 10-SB12G can be viewed online at: &filenum=&State=&SIC=&owner=include&action=getcompany)(Due to the length of the URL, please copy and paste into your browser.) Form 15c-211 reflects Columbus' full compliance with the SEC's new regulations and disclosure requirements. As soon as the SEC completes their review of the registration and disclosure statements, it is anticipated that Columbus will receive final approval to commence trading on the OTC Bulletin Board. The Company will report timely to the SEC as required by all reporting companies. "We have always been committed to become a fully reporting company and upgrade our trading status. We will hopefully soon achieve this goal as we anticipate a listing on the Bulletin Board in the very near future," said Columbus CEO Tsvika Freidman. "We are also committed to ultimately file for a listing on the NASDAQ-small cap. Once this is achieved, we anticipate that our company will be covered by more Wall Street analysts, and institutional investors will be attracted to our stock."
Nicely said Softy, some people are impatient and, due to having anger issues, then lash out at people. Hate is just a sign of internal conflicts and a lack of self esteem.
Who you calling "shortly"?
Doesn't that create a conundrum? If I believe you, then your statement is true, and I should'nt believe you.... If I don't believe you, then the statement is false, which conflicts with my not believing you. Damn, I've a headache now!
Mark Lewis - Board of Directors
It's not that they need to be buying shares, they need to be informing and showing us some progress. This is getting stale, is DPG back in charge, starting to feed like it!
Long coffee break by the printer, I guess.
I too have confidence this deal is going to get done, it's just frustrating waiting for the word.